Zürich, Switzerland, May 3, 2024 First data showing preliminary evidence of efficacy were presented at the Retinal Cell and Gene Therapy Innovation Summit organized by the Foundation Fighting Blindness (May 3rd, Seattle, Washington, US) by Dr. Byron Lam (Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami, Florida, USA): “First-in-human study to evaluate safety, tolerability and exploratory efficacy of a photoreceptor regeneration treatment with EA-2353 in patients with retinitis pigmentosa”

Byron L. Lam, Mark E. Pennesi, Victor Gonzalez, Abigail T. Fahim, David Birch, Paul Yang, Maria Gemenetzi, Susanne Raab, Johanna Vunder, Michelle Widmann, Lawrence J. Singerman, Moreno Menghini, Matthias Steger